M Janelle Cambron-Mellott

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Peritoneal Dialysis

Prognostic Factors

Patient Reported Outcomes

Ejection Fraction

Top Venues

Current medical research and opinion

Patient preference and adherence

Future oncology (London, England)

Brain and behavior

This page only lists publications with an associated author ORCID identifier.

Publications

Jon Vlasnik, M Janelle Cambron-Mellott, Halley Costantino, Mary Kunjappu
Burden of Wilson Disease among patients and care partners in the United States: results from a cross-sectional survey. Current medical research and opinion (2024)
Jon Vlasnik, M Janelle Cambron-Mellott, Halley Costantino, Mary Kunjappu
Burden of Wilson Disease among patients and care partners in the United States: results from a cross-sectional survey. Current medical research and opinion (2024)
Jon Vlasnik, M Janelle Cambron-Mellott, Halley Costantino, Mary Kunjappu
Burden of Wilson Disease among patients and care partners in the United States: results from a cross-sectional survey. Current medical research and opinion 40 (5) (2024)
Jon Vlasnik, M Janelle Cambron-Mellott, Halley Costantino, Mary Kunjappu
Burden of Wilson Disease among patients and care partners in the United States: results from a cross-sectional survey. Current medical research and opinion 40 (5) (2024)
Kruti Joshi, M Janelle Cambron-Mellott, Halley Costantino, Alanna Pfau, Manish Kumar Jha
The clinical, economic, and patient-centric burden of insomnia symptom severity in adults with major depressive disorder in the United States. Brain and behavior (2023)
Suvina Amin, Sara M Tolaney, M Janelle Cambron-Mellott, Kathleen Beusterien, Martine C Maculaitis, Emily Mulvihill, Reshma Shinde, Kimmie McLaurin
Benefit-risk trade-offs in treatment choice in advanced HER2 negative breast cancer: patient and oncologist perspectives. Future oncology (London, England) 18 (16) (2022)
Sanjay K Bajpai, M Janelle Cambron-Mellott, Oliver Will, Jiat-Ling Poon, Qianqian Wang, Beth D Mitchell, Eugenia Y Peck, Jane Babrowicz, Nedina K Raibulet, Christopher J Child, Kathleen Beusterien
Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Candice Yong, M Janelle Cambron-Mellott, Brian Seal, Oliver Will, Martine C Maculaitis, Kelly Clapp, Emily Mulvihill, Ion Cotarla, Ranee Mehra
Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment. Patient preference and adherence 16 (2022)
Jinender Kumar, M Janelle Cambron-Mellott, Tom Tencer, Oliver Will, deMauri S Mackie, Kathleen Beusterien
Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment. Patient preference and adherence 15 (2021)
Shonda A Foster, Bridget L Balkaran, M Janelle Cambron-Mellott, Karen H Samaan, Oksana Mason, Wenyu Ye, John C Rowland, Dena H Jaffe
Demographic and clinical characteristics of prevention-eligible patients with migraine in the US: a linked national survey and administrative claims database study. Current medical research and opinion 37 (3) (2021)
M Janelle Cambron-Mellott, Jaromir Mikl, Joana E Matos, Jennifer G Erensen, Kathleen Beusterien, Marc J Cataldo, Bernadette Hallissey, Gregory W Mattingly
Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment. Patient preference and adherence 15 (2021)
Tom Tencer, Oliver Will, Jinender Kumar, M Janelle Cambron-Mellott, deMauri S Mackie, Kathleen Beusterien
Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experiment. Current medical research and opinion 37 (9) (2021)
Rebecca L Stone, M Janelle Cambron-Mellott, Kathleen Beusterien, Martine C Maculaitis, Stephanie Ritz, Emily Mulvihill, Matthew Monberg, Elizabeth A Szamreta, Suvina Amin, Kimmie McLaurin
Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer. Future oncology (London, England) (2021)
Atsushi Araki, Hiroyuki Umegaki, Takashi Sakurai, Yuzo Mizuno, Mariko Miyao, Makoto Imori, Shuichi J Suzuki, M Janelle Cambron-Mellott, Koutaro Yokote, Tomio Onuma, Koichi Yokono
Determinants and impact of physical impairment in patient-reported outcomes among older patients with type 2 diabetes mellitus in Japan. Current medical research and opinion 37 (3) (2020)